Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Carboline compounds usable in the treatment of neurodegenerative diseases

Carboline compounds usable in the treatment of neurodegenerative diseases

US Patent 9714245 · Granted Jul 25, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of myotonic dystrophy2025
Cap for medical injector2024
Cap for medical injector2023
Cap with hemisphere portion for medical injector2021
Cap for medical injector2021
Compounds, pharmaceutical composition and their use in treating neurodegenerativ2020
Compounds, pharmaceutical composition and their use in treating neurodegenerativ2020
1,4-bis(3-aminopropyl)piperazine derivative and its use2020
1,4-bis(3-aminopropyl)piperazine derivative and its use2020
Treatment of myotonic dystrophy2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-b2020